| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/11/2023 | 1487.3% | HC Wainwright & Co. | → $10 | Reiterates | Buy → Buy |
| 05/08/2023 | 1487.3% | HC Wainwright & Co. | → $10 | Reiterates | → Buy |
| 04/04/2023 | 1487.3% | HC Wainwright & Co. | → $10 | Reiterates | → Buy |
| 03/28/2023 | 1487.3% | HC Wainwright & Co. | → $10 | Reiterates | → Buy |
| 09/06/2022 | 1487.3% | HC Wainwright & Co. | → $10 | Initiates Coverage On | → Buy |
| 07/19/2022 | 693.65% | B. Riley Securities | $6 → $5 | Maintains | Buy |
| 06/16/2021 | 1328.57% | B. Riley Securities | → $9 | Initiates Coverage On | → Buy |
| 03/22/2021 | 1804.76% | Aegis Capital | → $12 | Initiates Coverage On | → Buy |
What is the target price for Entera Bio (ENTX)?
The latest price target for Entera Bio (NASDAQ: ENTX) was reported by HC Wainwright & Co. on September 11, 2023. The analyst firm set a price target for $10.00 expecting ENTX to rise to within 12 months (a possible 1487.30% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Entera Bio (ENTX)?
The latest analyst rating for Entera Bio (NASDAQ: ENTX) was provided by HC Wainwright & Co., and Entera Bio reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Entera Bio (ENTX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Entera Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Entera Bio was filed on September 11, 2023 so you should expect the next rating to be made available sometime around September 11, 2024.
Is the Analyst Rating Entera Bio (ENTX) correct?
While ratings are subjective and will change, the latest Entera Bio (ENTX) rating was a reiterated with a price target of $0.00 to $10.00. The current price Entera Bio (ENTX) is trading at is $0.63, which is within the analyst's predicted range.